TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35255866

Group type: EXPERIMENTAL
Intervention: SPRAT programme
Number of subjects: 1986

Group type: COMPARATOR
Intervention: Control group (usual school programme)
Number of subjects: 1986
Study: 35010536

Group type: EXPERIMENTAL
Intervention: Kinesio taping with squat exercise (KTSE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham taping with squat exercise (SKTSE)
Number of subjects: 40
Study: 36036760

Group type: EXPERIMENTAL
Intervention: Full-dose anticoagulation
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 390

Group type: COMPARATOR
Intervention: Standard-dose prophylactic anticoagulation
Number of subjects: 390

Group type: COMPARATOR
Intervention: No antiplatelet therapy
Number of subjects: 390
Study: 33599794

Group type: EXPERIMENTAL
Intervention: DARA SC
Number of subjects: 67

Group type: COMPARATOR
Intervention: DARA IV
Number of subjects: 67
Study: 34816812

Group type: EXPERIMENTAL
Intervention: Highly cushioned running shoe (HCS)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control running shoe (CON)
Number of subjects: 32
Study: 32141136

Group type: EXPERIMENTAL
Intervention: Dietary AM/AP ratio of 0.23-0.35
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Dietary amylase at 6,000 U/kg
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Dietary AM/AP ratio increase
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: High AM/AP diet
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Amylase supplementation
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: High dose (6,000 U/kg) of amylase
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Exogenous amylase
Number of subjects: 960
Study: 33486048

Group type: EXPERIMENTAL
Intervention: Non-supervised aerobic exercise (20-minute low-impact aerobic exercise video, at least three times per week for three months)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Non-supervised aerobic exercise
Number of subjects: 140

Group type: COMPARATOR
Intervention: Routine prenatal care only
Number of subjects: 140
Study: 35653155

Group type: EXPERIMENTAL
Intervention: GWL packs
Number of subjects: 357

Group type: COMPARATOR
Intervention: Blank packs
Number of subjects: 357

Group type: COMPARATOR
Intervention: US packs
Number of subjects: 357
Study: 33002971

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition with protein supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early supplemental parenteral nutrition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early total parenteral nutrition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enteral feeding
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-dose vasopressors
Number of subjects: 0
Study: 35186243

Group type: EXPERIMENTAL
Intervention: Laparoscopic radical surgery combined with neoadjuvant chemotherapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Laparoscopic radical surgery
Number of subjects: 100
Study: 37267171

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) and general health education
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (general health education only)
Number of subjects: 101
Study: 33590330

Group type: EXPERIMENTAL
Intervention: Intervention group (some improvement)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control group (no improvement)
Number of subjects: 170
Study: 32448110

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 63
Study: 34266319

Group type: EXPERIMENTAL
Intervention: MIC-1 levels for detecting precancerous lesions
Number of subjects: 2759

Group type: EXPERIMENTAL
Intervention: MIC-1 levels for detecting colorectal cancer (CRC)
Number of subjects: 2759

Group type: COMPARATOR
Intervention: MIC-1 levels vs. CEA, CA19-9, CA24-2 for precancerous lesions
Number of subjects: 2759

Group type: COMPARATOR
Intervention: MIC-1 levels vs. CEA, CA19-9, CA24-2 for CRC
Number of subjects: 2759

Group type: EXPERIMENTAL
Intervention: Combination of MIC-1, CEA, CA19-9, CA24-2 for CRC diagnosis
Number of subjects: 2759
Study: 32242808

Group type: EXPERIMENTAL
Intervention: Musculoskeletal ultrasound (MUS) data shared with the primary rheumatologist
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group (MUS data not shared)
Number of subjects: 94
Study: 34039693

Group type: EXPERIMENTAL
Intervention: RAMP-group education (HBPM group education)
Number of subjects: 287

Group type: COMPARATOR
Intervention: RAMP-individual counselling (Control)
Number of subjects: 287
Study: 34817581

Group type: EXPERIMENTAL
Intervention: PRISM intervention
Number of subjects: 57
Study: 35168030

Group type: EXPERIMENTAL
Intervention: Equisetum arvense L. (EA) 900 mg/day
Number of subjects: 58

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) 25 mg/day
Number of subjects: 58
Study: 34078323

Group type: COMPARATOR
Intervention: Standard tacrolimus-based immunosuppressive regimen with mycophenolate mofetil and glucocorticoids
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Reduced CNI exposure in combination with everolimus and glucocorticoids
Number of subjects: 374
Study: 32249256

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation (TAVI) using J-Valve
Number of subjects: 18
Study: 32728879

Group type: EXPERIMENTAL
Intervention: 1 cup of espresso coffee/day
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 3 cups of espresso coffee/day
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 1 cup of espresso coffee plus 2 cocoa-based products containing coffee, twice per day
Number of subjects: 21
Study: 32068014

Group type: EXPERIMENTAL
Intervention: Copper-oxide-impregnated linens
Number of subjects: 1282

Group type: EXPERIMENTAL
Intervention: Copper-oxide-treated hard surfaces
Number of subjects: 1282

Group type: COMPARATOR
Intervention: Standard hospital linens
Number of subjects: 1282

Group type: COMPARATOR
Intervention: Control for central-line-associated bloodstream infections and catheter-associated urinary tract infections
Number of subjects: 1282
Study: 36347767

Group type: EXPERIMENTAL
Intervention: EVAHEART®2 left ventricular assist device (EVA2)
Number of subjects: 25

Group type: COMPARATOR
Intervention: HeartMate 3 LVAS (HM3)
Number of subjects: 25
Study: 33857946

Group type: EXPERIMENTAL
Intervention: Cabergoline
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32718144

Group type: EXPERIMENTAL
Intervention: High SIRI group (≥ 0.89)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Nomogram based on SIRI, body mass index, weight loss, carbohydrate antigen 19-9, radical surgery, and TNM stage
Number of subjects: 124

Group type: COMPARATOR
Intervention: Low SIRI group (< 0.89)
Number of subjects: 124
Study: 33245709

Group type: EXPERIMENTAL
Intervention: Lavender oil inhalation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Liquid paraffin (placebo) inhalation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Diclofenac intake
Number of subjects: 50
Study: 33417065

Group type: EXPERIMENTAL
Intervention: Direct trocar access (n = 68)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Veress needle access (n = 67)
Number of subjects: 135
Study: 35019896

Group type: EXPERIMENTAL
Intervention: Job crafting intervention program
Number of subjects: 281

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 281
Study: 34684438

Group type: EXPERIMENTAL
Intervention: 6-month lifestyle intervention program
Number of subjects: 259
Study: 32205528

Group type: EXPERIMENTAL
Intervention: Placebo intervention during green screens
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Same experimenter-participant race
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Different sex of experimenter and participant
Number of subjects: 372
Study: 35959712

Group type: EXPERIMENTAL
Intervention: Large-particle (LP) size graft (1000–2000 μm)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Small-particle (SP) size graft (250–1000 μm)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (LP)
Number of subjects: 22
Study: 32148181

Group type: EXPERIMENTAL
Intervention: School nurse-led asthma intervention
Number of subjects: 0
Study: 33541772

Group type: EXPERIMENTAL
Intervention: Periarticular injection (PAI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional pain control (non-PAI)
Number of subjects: 0
Study: 32812320

Group type: EXPERIMENTAL
Intervention: Andecaliximab 800 mg every 2 weeks in combination with gemcitabine and nab-paclitaxel
Number of subjects: 36
Study: 33213288

Group type: EXPERIMENTAL
Intervention: Intravenous alteplase
Number of subjects: 147

Group type: COMPARATOR
Intervention: No intravenous alteplase
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Early recanalization
Number of subjects: 147

Group type: COMPARATOR
Intervention: No early recanalization
Number of subjects: 147
Study: 32538889

Group type: EXPERIMENTAL
Intervention: Visual biofeedback flutter device
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Auditory biofeedback flutter device
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Visual and auditory biofeedback flutter device
Number of subjects: 168

Group type: COMPARATOR
Intervention: Conventional flutter device
Number of subjects: 168
Study: 32795167

Group type: EXPERIMENTAL
Intervention: Vitamin D3
Number of subjects: 239

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study: 33825512

Group type: EXPERIMENTAL
Intervention: PVE with N-Butyl-Cyanoacrylate (NBCA) plus iodized oil
Number of subjects: 60

Group type: COMPARATOR
Intervention: PVE with Polyvinyl Alcohol (PVA) particles plus coils
Number of subjects: 60
Study: 34579049

Group type: EXPERIMENTAL
Intervention: Test fermented milk containing yogurt and Lacticaseibacillus strains (L. paracasei CNCM I‐1518 and I‐3689, L. rhamnosus CNCM I‐3690) for 28 days
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control product for 28 days
Number of subjects: 136
Study: 35429325

Group type: EXPERIMENTAL
Intervention: Intermittent mask CPAP (ICPAP)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Continuous helmet CPAP (HCPAP)
Number of subjects: 96
Study: 33914256

Group type: EXPERIMENTAL
Intervention: MB02 (bevacizumab biosimilar)
Number of subjects: 627

Group type: COMPARATOR
Intervention: EU-bevacizumab (15 mg/kg)
Number of subjects: 627

Group type: EXPERIMENTAL
Intervention: MB02
Number of subjects: 627

Group type: COMPARATOR
Intervention: EU-bevacizumab
Number of subjects: 627

Group type: EXPERIMENTAL
Intervention: MB02 and EU-bevacizumab
Number of subjects: 627
Study: 35428320

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 25 mg/week
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 32956255

Group type: EXPERIMENTAL
Intervention: Suicide Risk Management (SRM) protocol
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Home visits
Number of subjects: 51
Study: 32772617

Group type: EXPERIMENTAL
Intervention: Eculizumab (Soliris®)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34348263

Group type: EXPERIMENTAL
Intervention: Additional L-carnitine (1,500 mg/day) and rifaximin (1,200 mg/day)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Rifaximin (1,200 mg/day)
Number of subjects: 83
Study: 32207689

Group type: EXPERIMENTAL
Intervention: Internet intervention (Deprexis) with email support
Number of subjects: 223
Study: 37002653

Group type: EXPERIMENTAL
Intervention: CBP quadruple therapy (amoxicillin 1 g twice daily, tetracycline 500 mg three times daily, esomeprazole 20 mg twice daily, CBP 200 mg three times daily)
Number of subjects: 339

Group type: COMPARATOR
Intervention: BPC quadruple therapy (amoxicillin 1 g twice daily, tetracycline 500 mg three times daily, esomeprazole 20 mg twice daily, BPC 240 mg twice daily)
Number of subjects: 339
Study: 33116029

Group type: EXPERIMENTAL
Intervention: cream-type denture adhesive
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: powder-type denture adhesive
Number of subjects: 200

Group type: COMPARATOR
Intervention: control (saline solution)
Number of subjects: 200
Study: 32744919

Group type: EXPERIMENTAL
Intervention: 660 nm PBMT (BFR strengthening with 660 nm PBMT‐35 mW; 0.05 cm2; 2.10 J, total energy 18.9 J)
Number of subjects: 58

Group type: COMPARATOR
Intervention: 830 nm PBMT (BFR strengthening with 830 nm PBMT‐32 mW; 0.101 cm2; 1.92 J, total energy 17.2 J)
Number of subjects: 58

Group type: COMPARATOR
Intervention: BFR (strengthening with blood flow restriction)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 660 nm PBMT (BFR strengthening with 660 nm PBMT)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (conventional strengthening)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 660 nm PBMT
Number of subjects: 58
Study: 35099030

Group type: EXPERIMENTAL
Intervention: Closed reduction initially preferred, followed by open reduction with percutaneous pinning when necessary.
Number of subjects: 112
Study: 32979921

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 412
Study: 36037823

Group type: EXPERIMENTAL
Intervention: HPV vaccine
Number of subjects: 7372

Group type: COMPARATOR
Intervention: Control (hepatitis E vaccine)
Number of subjects: 7372
Study: 34383535

Group type: EXPERIMENTAL
Intervention: Group mindfulness-based cognitive therapy (MBCT)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Group supportive sex education and therapy (STEP)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 148
Study: 35965904

Group type: EXPERIMENTAL
Intervention: Intralesional tranexamic acid (TXA) 4 mg/mL
Number of subjects: 68

Group type: COMPARATOR
Intervention: Topical Kligman's therapy
Number of subjects: 68
Study: 36401254

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise
Number of subjects: 90

Group type: COMPARATOR
Intervention: Resistance training
Number of subjects: 90
Study: 36109141

Group type: EXPERIMENTAL
Intervention: Third COVID-19 vaccination with an mRNA vaccine
Number of subjects: 60
Study: 34469855

Group type: EXPERIMENTAL
Intervention: Normal condition (no ADS failure)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Fault condition (ADS failure)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Both conditions (normal and fault)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 261
Study: 32767712

Group type: EXPERIMENTAL
Intervention: Culturally appropriate colour photograph (CP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Black-and-white line drawing (LD)
Number of subjects: 30
Study: 35309844

Group type: EXPERIMENTAL
Intervention: Danzhi Xiaoyao Powder combined with photodynamic therapy (PDT)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Photodynamic therapy (PDT)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Danzhi Xiaoyao Powder combined with PDT
Number of subjects: 110
Study: 33629961

Group type: EXPERIMENTAL
Intervention: POP4Teens (P4T)
Number of subjects: 406

Group type: COMPARATOR
Intervention: JustThinkTwice (JTT)
Number of subjects: 406
Study: 32623011

Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied to the right temporo-parietal junction (TPJ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anodal tDCS applied to the left temporo-parietal junction (TPJ)
Number of subjects: 0
Study: 35030270

Group type: EXPERIMENTAL
Intervention: Revitalization with the blood clot (BC) technique
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)-based technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 20
Study: 34230452

Group type: EXPERIMENTAL
Intervention: mTBI decrease to less than 0.02% at the first tumor evaluation
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: high-level pretreatment mTBI
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: mTBI as a biomarker
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: molecular responders
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: mTBI in ctDNA
Number of subjects: 125
Study: 32632703

Group type: EXPERIMENTAL
Intervention: Displacement without reduction (DWoR) group (n = 25)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Displacement with reduction (DWR) group (n = 32)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Normal disc position (ND) group (n = 37)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Non-temporomandibular joint disc displacement (non-TMJD) patients
Number of subjects: 47
Study: 33894496

Group type: EXPERIMENTAL
Intervention: 61.2 Gy concomitant boost (CB)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 70 Gy daily (QD)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Cisplatin and etoposide chemotherapy with TRT regimens
Number of subjects: 140
Study: 32605881

Group type: EXPERIMENTAL
Intervention: Community-based lifestyle intervention delivered by lay health coaches
Number of subjects: 221
Study: 33357808

Group type: EXPERIMENTAL
Intervention: Aging Treatment Model
Number of subjects: 230
Study: 35445986

Group type: EXPERIMENTAL
Intervention: ECCO2R
Number of subjects: 18

Group type: COMPARATOR
Intervention: NIV
Number of subjects: 18
Study: 33620233

Group type: EXPERIMENTAL
Intervention: High-protein hypocaloric diet (diet HP)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Standard hypocaloric diet (diet S)
Number of subjects: 269
Study: 32366124

Group type: EXPERIMENTAL
Intervention: Therapy (38 participants)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Advice (33 participants)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Device (39 participants)
Number of subjects: 222
Study: 35028950

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Valproic acid
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 34278743

Group type: EXPERIMENTAL
Intervention: Balance plus moderate endurance training
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Moderate endurance training only
Number of subjects: 31

Group type: COMPARATOR
Intervention: Healthy control participants (hCON)
Number of subjects: 31
Study: 32054355

Group type: EXPERIMENTAL
Intervention: MYO + ALA
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control
Number of subjects: 23
Study: 36164047

Group type: EXPERIMENTAL
Intervention: R-DA-EPOCH-21
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: R-mNHL-BFM-90
Number of subjects: 140

Group type: COMPARATOR
Intervention: R-DA-EPOCH-21 ± auto-HSCT
Number of subjects: 140

Group type: COMPARATOR
Intervention: R-mNHL-BFM-90 ± auto-HSCT
Number of subjects: 140
Study: 34292298

Group type: EXPERIMENTAL
Intervention: Active mode (collision warning device providing alerts via vibrotactile wristbands)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Silent mode (collision warning device detecting collisions without providing warnings)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Active mode
Number of subjects: 31
Study: 32740327

Group type: EXPERIMENTAL
Intervention: Mind Map-Based Life Review Program (MBLRP) plus routine care
Number of subjects: 84

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 84
Study: 33983396

Group type: EXPERIMENTAL
Intervention: Switch to non-menthol cigarettes
Number of subjects: 122

Group type: COMPARATOR
Intervention: Continue smoking menthol cigarettes
Number of subjects: 122
Study: 32896022

Group type: EXPERIMENTAL
Intervention: 200 mg Panax quinquefolius
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34282720

Group type: EXPERIMENTAL
Intervention: Low glutamate diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monosodium glutamate (MSG) challenge
Number of subjects: 0
Study: 34534488

Group type: EXPERIMENTAL
Intervention: Family-based intervention including screening for cardiovascular risk factors, structured lifestyle interventions, linkage to primary health-care, and active follow-up.
Number of subjects: 1671

Group type: COMPARATOR
Intervention: Usual care group receiving one-time counselling and annual screening for risk factors.
Number of subjects: 1671
Study: 35368763

Group type: EXPERIMENTAL
Intervention: Kleeb Bua Daeng (KBD) formula, 1,000 mg twice a day for three months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Kleeb Bua Daeng (KBD) formula
Number of subjects: 40
Study: 33862582

Group type: COMPARATOR
Intervention: gemcitabine
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: gemcitabine + erlotinib
Number of subjects: 293
Study: 35312788

Group type: EXPERIMENTAL
Intervention: Be ACTIVE
Number of subjects: 50

Group type: COMPARATOR
Intervention: Enhanced control condition
Number of subjects: 50
Study: 33253210

Group type: EXPERIMENTAL
Intervention: Standard antifungal treatment with adjunctive dexamethasone
Number of subjects: 211

Group type: COMPARATOR
Intervention: Standard antifungal treatment without adjunctive dexamethasone
Number of subjects: 211
Study: 34450354

Group type: EXPERIMENTAL
Intervention: Saphenofemoral ligation and stripping (SFL/S)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Endovenous laser ablation (EVLA)
Number of subjects: 122
Study: 33647393

Group type: EXPERIMENTAL
Intervention: Urine KIM-1
Number of subjects: 2253

Group type: EXPERIMENTAL
Intervention: Urine MCP-1
Number of subjects: 2253

Group type: EXPERIMENTAL
Intervention: Urine A1M
Number of subjects: 2253

Group type: EXPERIMENTAL
Intervention: Urine B2M
Number of subjects: 2253

Group type: EXPERIMENTAL
Intervention: Urine albumin
Number of subjects: 2253
Study: 32039689

Group type: EXPERIMENTAL
Intervention: Fragrance inhalation of grapefruit essential oil for 10 minutes (study 1)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Fragrance inhalation of grapefruit essential oil for 10 minutes (study 2)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Fragrance inhalation of grapefruit essential oil (last 5 minutes of inhalation)
Number of subjects: 22
Study: 34106270

Group type: EXPERIMENTAL
Intervention: Integration of external control data into interim analyses (IAs)
Number of subjects: 0
Study: 32608134

Group type: COMPARATOR
Intervention: ARE0 (0 g kg-1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ARE20 (20 g kg-1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ARE50 (50 g kg-1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ARE80 (80 g kg-1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ARE (5% to 8% DMI)
Number of subjects: 24
Study: 34971398

Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy (AT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Rapid maxillary expansion (RME)
Number of subjects: 39